N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.

Por Fischer, P B, Karlsson, G B, Dwek, R A, Platt, F M
Publicado em 1996

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.

Por Fischer, P B, Karlsson, G B, Butters, T D, Dwek, R A, Platt, F M
Publicado em 1996

Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis.

Por Moestrup, S K, Birn, H, Fischer, P B, Petersen, C M, Verroust, P J, Sim, R B, Christensen, E I, Nexø, E
Publicado em 1996

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Por Fischer, P B, Collin, M, Karlsson, G B, James, W, Butters, T D, Davis, S J, Gordon, S, Dwek, R A, Platt, F M
Publicado em 1995